Belantamab mafodotin with bortezomib and dexamethasone for previously treated multiple myeloma

  • Technology appraisal guidance
  • TA1149
  • Published: 

Tools and resources

Tools and resources to help you put the guidance into practice.

Resource impact

Guidance into practice